AFFINITY ASSET ADVISORS, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ERAS | 4.29M | $9.34M |
 | VTYX | 3.92M | $12.20M |
 | LXEO | 3.87M | $25.70M |
 | PRQR | 3.60M | $7.67M |
 | TSHA | 3.00M | $9.81M |
 | TRVI | 2.80M | $25.62M |
 | OVID | 2.65M | $3.44M |
 | AKBA | 2.45M | $6.69M |
 | WVE | 2.10M | $15.37M |
 | RZLT | 2.10M | $19.74M |
 | AUTL | 1.75M | $2.85M |
 | GERN | 1.50M | $2.06M |
 | SVRA | 1.50M | $5.36M |
 | SYRE | 1.42M | $23.79M |
 | TEVA | 1.40M | $28.28M |
 | XENE | 1.40M | $56.21M |
 | ZURA | 1.27M | $5.52M |
 | ALKS | 1.25M | $37.50M |
 | APGE | 1.17M | $46.62M |
 | CNTA | 1.11M | $26.85M |
Erasca, Inc.
ERAS
Shares Held
4.29M
Value
$9.34M
Ventyx Biosciences, Inc.
VTYX
Shares Held
3.92M
Value
$12.20M
Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
3.87M
Value
$25.70M
ProQR Therapeutics N.V.
PRQR
Shares Held
3.60M
Value
$7.67M
Taysha Gene Therapies, Inc.
TSHA
Shares Held
3.00M
Value
$9.81M
Trevi Therapeutics, Inc.
TRVI
Shares Held
2.80M
Value
$25.62M
Ovid Therapeutics Inc.
OVID
Shares Held
2.65M
Value
$3.44M
Akebia Therapeutics, Inc.
AKBA
Shares Held
2.45M
Value
$6.69M
Wave Life Sciences Ltd.
WVE
Shares Held
2.10M
Value
$15.37M
Rezolute, Inc.
RZLT
Shares Held
2.10M
Value
$19.74M
Autolus Therapeutics plc
AUTL
Shares Held
1.75M
Value
$2.85M
Geron Corporation
GERN
Shares Held
1.50M
Value
$2.06M
Savara Inc.
SVRA
Shares Held
1.50M
Value
$5.36M
Spyre Therapeutics, Inc.
SYRE
Shares Held
1.42M
Value
$23.79M
Teva Pharmaceutical Industries Limited
TEVA
Shares Held
1.40M
Value
$28.28M
Xenon Pharmaceuticals Inc.
XENE
Shares Held
1.40M
Value
$56.21M
Zura Bio Limited
ZURA
Shares Held
1.27M
Value
$5.52M
Alkermes plc
ALKS
Shares Held
1.25M
Value
$37.50M
Apogee Therapeutics, Inc.
APGE
Shares Held
1.17M
Value
$46.62M
Centessa Pharmaceuticals plc
CNTA
Shares Held
1.11M
Value
$26.85M